Improved participants’ understanding in a healthy volunteer study using the SIDCER informed consent form: a randomized-controlled study

Purpose This study aimed to evaluate the applicability of the principles and informed consent form (ICF) template proposed by the Strategic Initiative for Developing Capacity in Ethical Review (SIDCER) in a clinical pharmacokinetic study by comparing the volunteers’ understanding of the enhanced ICF...

Full description

Saved in:
Bibliographic Details
Published inEuropean journal of clinical pharmacology Vol. 72; no. 4; pp. 413 - 421
Main Authors Koonrungsesomboon, Nut, Teekachunhatean, Supanimit, Hanprasertpong, Nutthiya, Laothavorn, Junjira, Na-Bangchang, Kesara, Karbwang, Juntra
Format Journal Article
LanguageEnglish
Published Berlin/Heidelberg Springer Berlin Heidelberg 01.04.2016
Springer Nature B.V
Subjects
Online AccessGet full text
ISSN0031-6970
1432-1041
DOI10.1007/s00228-015-2000-2

Cover

Abstract Purpose This study aimed to evaluate the applicability of the principles and informed consent form (ICF) template proposed by the Strategic Initiative for Developing Capacity in Ethical Review (SIDCER) in a clinical pharmacokinetic study by comparing the volunteers’ understanding of the enhanced ICF (developed based on the SIDCER methodology) and the conventional ICF (which was previously approved by local Ethics Committee and used in the clinical study). Methods A total of 550 volunteers were randomly assigned to read either the enhanced ICF or the conventional ICF (1:1) in a mock informed consent approach and subsequently performed the post-test questionnaire. The primary endpoint was the proportion of the participants who had the post-test score of ≥80 %; the secondary endpoints were the total score of the post-test, the score of the categorized ICF elements, and time spent for participation. Results The proportion of the participants in the enhanced ICF group who achieved the primary endpoint was significantly higher than the conventional ICF group (82.2 % vs. 60.4 %, p  < 0.001). The participants in the enhanced ICF group obtained higher scores and spent less time in reading the given ICF and answering the post-test than those in the conventional ICF group (total score 19/21 vs. 18/21, p  < 0.001; time spent 20 min vs. 25 min, p  < 0.001). Conclusion The enhanced ICF improved the understanding of the participants in this study. This demonstrates the applicability of the SIDCER ICF principles and its template in the development of an enhanced ICF for improving the quality of ICFs and subjects’ understanding in clinical research. Trial registration: TCTR20140727001
AbstractList This study aimed to evaluate the applicability of the principles and informed consent form (ICF) template proposed by the Strategic Initiative for Developing Capacity in Ethical Review (SIDCER) in a clinical pharmacokinetic study by comparing the volunteers' understanding of the enhanced ICF (developed based on the SIDCER methodology) and the conventional ICF (which was previously approved by local Ethics Committee and used in the clinical study). A total of 550 volunteers were randomly assigned to read either the enhanced ICF or the conventional ICF (1:1) in a mock informed consent approach and subsequently performed the post-test questionnaire. The primary endpoint was the proportion of the participants who had the post-test score of ≥ 80 %; the secondary endpoints were the total score of the post-test, the score of the categorized ICF elements, and time spent for participation. The proportion of the participants in the enhanced ICF group who achieved the primary endpoint was significantly higher than the conventional ICF group (82.2 % vs. 60.4 %, p < 0.001). The participants in the enhanced ICF group obtained higher scores and spent less time in reading the given ICF and answering the post-test than those in the conventional ICF group (total score 19/21 vs. 18/21, p < 0.001; time spent 20 min vs. 25 min, p < 0.001). The enhanced ICF improved the understanding of the participants in this study. This demonstrates the applicability of the SIDCER ICF principles and its template in the development of an enhanced ICF for improving the quality of ICFs and subjects' understanding in clinical research. TCTR20140727001.
Purpose This study aimed to evaluate the applicability of the principles and informed consent form (ICF) template proposed by the Strategic Initiative for Developing Capacity in Ethical Review (SIDCER) in a clinical pharmacokinetic study by comparing the volunteers’ understanding of the enhanced ICF (developed based on the SIDCER methodology) and the conventional ICF (which was previously approved by local Ethics Committee and used in the clinical study). Methods A total of 550 volunteers were randomly assigned to read either the enhanced ICF or the conventional ICF (1:1) in a mock informed consent approach and subsequently performed the post-test questionnaire. The primary endpoint was the proportion of the participants who had the post-test score of ≥80 %; the secondary endpoints were the total score of the post-test, the score of the categorized ICF elements, and time spent for participation. Results The proportion of the participants in the enhanced ICF group who achieved the primary endpoint was significantly higher than the conventional ICF group (82.2 % vs. 60.4 %, p  < 0.001). The participants in the enhanced ICF group obtained higher scores and spent less time in reading the given ICF and answering the post-test than those in the conventional ICF group (total score 19/21 vs. 18/21, p  < 0.001; time spent 20 min vs. 25 min, p  < 0.001). Conclusion The enhanced ICF improved the understanding of the participants in this study. This demonstrates the applicability of the SIDCER ICF principles and its template in the development of an enhanced ICF for improving the quality of ICFs and subjects’ understanding in clinical research. Trial registration: TCTR20140727001
Purpose This study aimed to evaluate the applicability of the principles and informed consent form (ICF) template proposed by the Strategic Initiative for Developing Capacity in Ethical Review (SIDCER) in a clinical pharmacokinetic study by comparing the volunteers' understanding of the enhanced ICF (developed based on the SIDCER methodology) and the conventional ICF (which was previously approved by local Ethics Committee and used in the clinical study). Methods A total of 550 volunteers were randomly assigned to read either the enhanced ICF or the conventional ICF (1:1) in a mock informed consent approach and subsequently performed the post-test questionnaire. The primary endpoint was the proportion of the participants who had the post-test score of [greater than or equal to]80 %; the secondary endpoints were the total score of the post-test, the score of the categorized ICF elements, and time spent for participation. Results The proportion of the participants in the enhanced ICF group who achieved the primary endpoint was significantly higher than the conventional ICF group (82.2 % vs. 60.4 %, p < 0.001). The participants in the enhanced ICF group obtained higher scores and spent less time in reading the given ICF and answering the post-test than those in the conventional ICF group (total score 19/21 vs. 18/21, p < 0.001; time spent 20 min vs. 25 min, p < 0.001). Conclusion The enhanced ICF improved the understanding of the participants in this study. This demonstrates the applicability of the SIDCER ICF principles and its template in the development of an enhanced ICF for improving the quality of ICFs and subjects' understanding in clinical research. Trial registration: TCTR20140727001
PURPOSEThis study aimed to evaluate the applicability of the principles and informed consent form (ICF) template proposed by the Strategic Initiative for Developing Capacity in Ethical Review (SIDCER) in a clinical pharmacokinetic study by comparing the volunteers' understanding of the enhanced ICF (developed based on the SIDCER methodology) and the conventional ICF (which was previously approved by local Ethics Committee and used in the clinical study).METHODSA total of 550 volunteers were randomly assigned to read either the enhanced ICF or the conventional ICF (1:1) in a mock informed consent approach and subsequently performed the post-test questionnaire. The primary endpoint was the proportion of the participants who had the post-test score of ≥ 80 %; the secondary endpoints were the total score of the post-test, the score of the categorized ICF elements, and time spent for participation.RESULTSThe proportion of the participants in the enhanced ICF group who achieved the primary endpoint was significantly higher than the conventional ICF group (82.2 % vs. 60.4 %, p < 0.001). The participants in the enhanced ICF group obtained higher scores and spent less time in reading the given ICF and answering the post-test than those in the conventional ICF group (total score 19/21 vs. 18/21, p < 0.001; time spent 20 min vs. 25 min, p < 0.001).CONCLUSIONThe enhanced ICF improved the understanding of the participants in this study. This demonstrates the applicability of the SIDCER ICF principles and its template in the development of an enhanced ICF for improving the quality of ICFs and subjects' understanding in clinical research.TRIAL REGISTRATIONTCTR20140727001.
Author Karbwang, Juntra
Laothavorn, Junjira
Koonrungsesomboon, Nut
Na-Bangchang, Kesara
Teekachunhatean, Supanimit
Hanprasertpong, Nutthiya
Author_xml – sequence: 1
  givenname: Nut
  surname: Koonrungsesomboon
  fullname: Koonrungsesomboon, Nut
  organization: Department of Clinical Product Development, Institute of Tropical Medicine, Nagasaki University, Leading Program, Graduate School of Biomedical Sciences, Nagasaki University
– sequence: 2
  givenname: Supanimit
  surname: Teekachunhatean
  fullname: Teekachunhatean, Supanimit
  organization: Department of Pharmacology, Faculty of Medicine, Chiang Mai University
– sequence: 3
  givenname: Nutthiya
  surname: Hanprasertpong
  fullname: Hanprasertpong, Nutthiya
  organization: Department of Pharmacology, Faculty of Medicine, Chiang Mai University
– sequence: 4
  givenname: Junjira
  surname: Laothavorn
  fullname: Laothavorn, Junjira
  organization: Chulabhorn International College of Medicine, Thammasat University
– sequence: 5
  givenname: Kesara
  surname: Na-Bangchang
  fullname: Na-Bangchang, Kesara
  organization: Chulabhorn International College of Medicine, Thammasat University
– sequence: 6
  givenname: Juntra
  surname: Karbwang
  fullname: Karbwang, Juntra
  email: karbwangj@nagasaki-u.ac.jp
  organization: Department of Clinical Product Development, Institute of Tropical Medicine, Nagasaki University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/26713336$$D View this record in MEDLINE/PubMed
BookMark eNp9kk9rFDEYh4NU7Lb6AbxIwIuX0TfJzGTHg1DWqgsFwT_nkGQyuykzyZhkFtaT136Efj0_iRm3lVrQUwh5fg-_JO8JOnLeGYSeEnhJAPirCEDpsgBSFRQACvoALUjJaEGgJEdoAcBIUTccjtFJjJeQwQbYI3RMa04YY_UCXa2HMfidafEoQ7LajtKl-PPHNZ5ca0JM0rXWbbB1WOKtkX3a7vHO95NLxgQc09Tu8RRnJG0N_rx-uzr_lOnOhyFLtXfRuITn7etsCFnnB_vdtEU-SsH3faZ-Wx6jh53so3lys56ir-_Ov6w-FBcf369XZxeFLjmkoluyxnRNoztddppRaABUqYyqdUWqumlKqduWE1WDNqCY6mpFuDIsQx1VnJ2iNwfvOKlcUed6QfZiDHaQYS-8tOLvE2e3YuN3ouQNZazKghc3guC_TSYmMdioTd9LZ_wUBeG8JBVvliSjz--hl34KLl9vphhlS07rTD272-hPldtfygA_ADr4GIPphLZJJju_oLS9ICDmeRCHeRD5m8U8D4LmJLmXvJX_L0MPmZhZtzHhTul_hn4B0Z7L5A
CitedBy_id crossref_primary_10_59398_ahd_1298248
crossref_primary_10_1177_17407745231174528
crossref_primary_10_1016_j_cct_2022_106733
crossref_primary_10_1080_10508422_2017_1320665
crossref_primary_10_1136_bmjopen_2019_029530
crossref_primary_10_1186_s12910_020_0445_z
crossref_primary_10_1136_archdischild_2017_312615
crossref_primary_10_1007_s00228_019_02738_6
crossref_primary_10_1177_1740774519834257
crossref_primary_10_11111_jkana_2017_23_3_223
crossref_primary_10_1007_s00228_016_2159_1
crossref_primary_10_1186_s12910_018_0318_x
crossref_primary_10_1371_journal_pone_0164251
Cites_doi 10.1016/S0893-133X(00)00218-9
10.1007/s10461-011-9977-z
10.1016/j.cct.2012.04.005
10.1093/qjmed/hcn067
10.1056/NEJMoa063842
10.1016/S0140-6736(02)11338-9
10.1136/medethics-2012-101115
10.1056/NEJMsa021212
10.1097/MJT.0b013e3182811a9e
10.1111/j.1472-8206.2007.00472.x
10.1016/j.jcmg.2012.03.007
10.1136/jme.2008.026708
10.1371/journal.pone.0105720
10.1007/s11606-011-1778-6
10.1111/j.1553-2712.2010.00985.x
10.1001/jama.292.13.1593
10.1016/S0140-6736(06)69881-4
10.1093/annonc/mdn623
10.1186/1472-6939-14-28
10.1080/09540120600680882
10.1111/j.1365-2125.2009.03565.x
10.1097/01.coc.0000135925.83221.b3
10.1177/1740774513515550
10.1200/JCO.2006.10.3341
10.2188/jea.JE20110104
10.1016/j.cct.2011.05.012
ContentType Journal Article
Copyright The Author(s) 2015
Springer-Verlag Berlin Heidelberg 2016
Copyright_xml – notice: The Author(s) 2015
– notice: Springer-Verlag Berlin Heidelberg 2016
DBID C6C
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7RV
7TK
7U9
7X7
7XB
88E
8AO
8FI
8FJ
8FK
ABUWG
AFKRA
BENPR
CCPQU
FYUFA
GHDGH
H94
K9.
KB0
M0S
M1P
NAPCQ
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOI 10.1007/s00228-015-2000-2
DatabaseName Springer Nature OA Free Journals
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
ProQuest Nursing and Allied Health Journals - PSU access expires 11/30/25.
Neurosciences Abstracts
Virology and AIDS Abstracts
ProQuest Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Database Suite (ProQuest)
ProQuest One Community College
Health Research Premium Collection
Health Research Premium Collection (Alumni)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
ProQuest Health & Medical Collection
Medical Database
Nursing & Allied Health Premium
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest One Academic Middle East (New)
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Pharma Collection
ProQuest Central China
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Health & Medical Research Collection
AIDS and Cancer Research Abstracts
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Virology and AIDS Abstracts
ProQuest One Academic Eastern Edition
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE

ProQuest One Academic Middle East (New)
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1432-1041
EndPage 421
ExternalDocumentID PMC4792335
3984815531
26713336
10_1007_s00228_015_2000_2
Genre Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Journal Article
Feature
GrantInformation_xml – fundername: World Health Organization
  grantid: SPHQ14-LOA-236
  funderid: http://dx.doi.org/10.13039/100004423
– fundername: ;
  grantid: SPHQ14-LOA-236
GroupedDBID ---
-4W
-56
-5G
-BR
-EM
-Y2
-~C
.86
.GJ
.VR
04C
06C
06D
0R~
0VY
199
1N0
1SB
2.D
203
28-
29G
29~
2J2
2JN
2JY
2KG
2KM
2LR
2P1
2VQ
2~H
30V
36B
3O-
3SX
3V.
4.4
406
408
409
40D
40E
53G
5QI
5RE
5VS
67N
67Z
6NX
6PF
78A
7RV
7X7
88E
8AO
8FI
8FJ
8FW
8TC
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AACDK
AAHNG
AAIAL
AAJBT
AAJKR
AANXM
AANZL
AARHV
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAWTL
AAYIU
AAYOK
AAYQN
AAYTO
AAYZH
ABAKF
ABBBX
ABBXA
ABDZT
ABECU
ABFTV
ABHLI
ABHQN
ABIPD
ABJNI
ABJOX
ABKCH
ABKTR
ABLJU
ABMNI
ABMQK
ABNWP
ABPLI
ABQBU
ABQSL
ABSXP
ABTEG
ABTHY
ABTKH
ABTMW
ABULA
ABUWG
ABWNU
ABXPI
ACAOD
ACBXY
ACDTI
ACGFO
ACGFS
ACHSB
ACHVE
ACHXU
ACIHN
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPIV
ACPRK
ACREN
ACZOJ
ADBBV
ADHHG
ADHIR
ADINQ
ADJJI
ADKNI
ADKPE
ADOJX
ADRFC
ADTPH
ADURQ
ADYFF
ADYOE
ADYPR
ADZKW
AEAQA
AEBTG
AEFIE
AEFQL
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AETLH
AEVLU
AEXYK
AFBBN
AFDYV
AFEXP
AFFNX
AFGCZ
AFKRA
AFLOW
AFQWF
AFRAH
AFWTZ
AFYQB
AFZKB
AGAYW
AGDGC
AGGDS
AGJBK
AGMZJ
AGQEE
AGQMX
AGRTI
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHIZS
AHKAY
AHMBA
AHSBF
AHYZX
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AJBLW
AJRNO
AJZVZ
AKMHD
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMTXH
AMXSW
AMYLF
AMYQR
AOCGG
ARMRJ
ASPBG
AVWKF
AXYYD
AZFZN
B-.
BA0
BBWZM
BDATZ
BENPR
BGNMA
BKEYQ
BMSDO
BPHCQ
BSONS
BVXVI
C6C
CAG
CCPQU
COF
CS3
CSCUP
DDRTE
DL5
DNIVK
DPUIP
DU5
EBD
EBLON
EBS
ECT
EIHBH
EIOEI
EJD
EMB
EMOBN
EN4
EPAXT
ESBYG
EX3
F5P
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
FYUFA
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNWQR
GQ6
GQ7
GQ8
GXS
H13
HF~
HG5
HG6
HMCUK
HMJXF
HQYDN
HRMNR
HVGLF
HZ~
I09
IHE
IJ-
IKXTQ
IMOTQ
ITM
IWAJR
IXC
IZIGR
IZQ
I~X
I~Z
J-C
J0Z
JBSCW
JCJTX
JZLTJ
KDC
KOV
KOW
KPH
LAS
LLZTM
M1P
M4Y
MA-
MK0
N2Q
N9A
NAPCQ
NB0
NDZJH
NPVJJ
NQJWS
NU0
O9-
O93
O9G
O9I
O9J
OAM
P19
P2P
PF0
PQQKQ
PROAC
PSQYO
PT4
PT5
Q2X
QOK
QOR
QOS
R4E
R89
R9I
RHV
RIG
RNI
ROL
RPX
RRX
RSV
RZK
S16
S1Z
S26
S27
S28
S3A
S3B
SAP
SBL
SBY
SCLPG
SDH
SDM
SHX
SISQX
SJYHP
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SV3
SZN
T13
T16
TSG
TSK
TSV
TUC
U2A
U9L
UG4
UKHRP
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W23
W48
WJK
WK6
WK8
WOW
Y6R
YLTOR
Z45
Z7U
Z7V
Z7W
Z81
Z82
Z83
Z87
Z8O
Z8P
Z8Q
Z8U
Z8V
Z8W
Z91
ZGI
ZMTXR
ZOVNA
ZXP
~EX
~KM
AAPKM
AAYXX
ABBRH
ABDBE
ABFSG
ACMFV
ACSTC
ADHKG
AEZWR
AFDZB
AFHIU
AFOHR
AGQPQ
AHPBZ
AHWEU
AIXLP
ATHPR
AYFIA
CITATION
PHGZM
PHGZT
CGR
CUY
CVF
ECM
EIF
NPM
7TK
7U9
7XB
8FK
ABRTQ
H94
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQUKI
PRINS
7X8
PUEGO
5PM
ID FETCH-LOGICAL-c470t-f839ef99cfc4fc320900b4beb6c5156994acdd71b60ce0b3bf6b17be3b4bf2b73
IEDL.DBID AGYKE
ISSN 0031-6970
IngestDate Thu Aug 21 18:06:12 EDT 2025
Fri Sep 05 05:56:59 EDT 2025
Fri Jul 25 07:35:17 EDT 2025
Wed Feb 19 02:00:37 EST 2025
Tue Jul 01 01:41:13 EDT 2025
Thu Apr 24 22:55:07 EDT 2025
Fri Feb 21 02:34:23 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords Understanding
Informed consent
Clinical research
Healthy subjects
Healthy volunteers
Clinical study
Language English
License Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c470t-f839ef99cfc4fc320900b4beb6c5156994acdd71b60ce0b3bf6b17be3b4bf2b73
Notes SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 14
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
ObjectType-Undefined-3
OpenAccessLink https://proxy.k.utb.cz/login?url=https://link.springer.com/10.1007/s00228-015-2000-2
PMID 26713336
PQID 1773238726
PQPubID 47171
PageCount 9
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_4792335
proquest_miscellaneous_1774157981
proquest_journals_1773238726
pubmed_primary_26713336
crossref_citationtrail_10_1007_s00228_015_2000_2
crossref_primary_10_1007_s00228_015_2000_2
springer_journals_10_1007_s00228_015_2000_2
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2016-04-01
PublicationDateYYYYMMDD 2016-04-01
PublicationDate_xml – month: 04
  year: 2016
  text: 2016-04-01
  day: 01
PublicationDecade 2010
PublicationPlace Berlin/Heidelberg
PublicationPlace_xml – name: Berlin/Heidelberg
– name: Germany
– name: Heidelberg
PublicationTitle European journal of clinical pharmacology
PublicationTitleAbbrev Eur J Clin Pharmacol
PublicationTitleAlternate Eur J Clin Pharmacol
PublicationYear 2016
Publisher Springer Berlin Heidelberg
Springer Nature B.V
Publisher_xml – name: Springer Berlin Heidelberg
– name: Springer Nature B.V
References Paasche-Orlow, Taylor, Brancati (CR11) 2003; 348
Dunn, Jeste (CR17) 2001; 24
Nishimura, Carey, Erwin, Tilburt, Murad, McCormick (CR16) 2013; 14
Paris, Brandt, Cornu, Maison, Thalamas, Cracowski (CR22) 2010; 69
CR14
Flory, Emanuel (CR28) 2004; 292
Fortun, West, Chalkley, Shonde, Hawkey (CR6) 2008; 101
Sanchini, Reni, Calori, Riva, Reichlin (CR29) 2014; 40
Kass, Chaisson, Taylor, Lohse (CR10) 2011; 26
Knapp, Raynor, Silcock, Parkinson (CR3) 2009; 35
Berger, Grønberg, Sand, Kaasa, Loge (CR9) 2009; 20
Matsui, Lie, Turin, Kita (CR21) 2012; 22
Apseloff, Kitzmiller, Tishler (CR5) 2013; 20
Arora, Rajagopalan, Shafiq, Pandhi, Bhalla, Dhibar, Malhotra (CR4) 2011; 32
Fitzgerald, Marotte, Verdier, Johnson, Pape (CR7) 2002; 360
Sharp (CR8) 2004; 27
MacQueen, Chen, Ramirez, Nnko, Earp (CR26) 2014; 9
Mohr, Moreno-Walton, Mills, Brunett, Promes (CR27) 2011; 18
Paris, Nogueira da Gama Chaves, Cornu, Maison, Salvat-Mélis, Ribuot, Brandt, Bosson, Hommel, Cracowski (CR25) 2007; 21
Lancaster, Stillman (CR18) 2002
Enama, Hu, Gordon, Costner, Ledgerwood, Grady, Teams (CR23) 2012; 33
Sato, Watanabe, Katsumata, Sato, Ohashi (CR24) 2014; 11
Beardsley, Jefford, Mileshkin (CR13) 2007; 25
Terranova, Ferro, Carpeggiani, Recchia, Braga, Semelka, Picano (CR12) 2012; 5
Malik, Mejia (CR15) 2014; 6
Murphy, Hoffman, Seage, Belzer, Xu, Durako, Geiger (CR20) 2007; 19
Corneli, Sorenson, Bentley, Henderson, Bowling, Nkhoma, Moses, Zulu, Chilima, Ahmed, Heilig, Jamieson, van der Horst (CR19) 2012; 16
Suntharalingam, Perry, Ward, Brett, Castello-Cortes, Brunner, Panoskaltsis (CR1) 2006; 355
Sugarman, Levine (CR2) 2006; 368
G Suntharalingam (2000_CR1) 2006; 355
J Sugarman (2000_CR2) 2006; 368
G Apseloff (2000_CR5) 2013; 20
LC Lancaster (2000_CR18) 2002
NM Mohr (2000_CR27) 2011; 18
L Malik (2000_CR15) 2014; 6
G Terranova (2000_CR12) 2012; 5
MK Paasche-Orlow (2000_CR11) 2003; 348
NE Kass (2000_CR10) 2011; 26
A Paris (2000_CR25) 2007; 21
A Nishimura (2000_CR16) 2013; 14
A Paris (2000_CR22) 2010; 69
AL Corneli (2000_CR19) 2012; 16
KM MacQueen (2000_CR26) 2014; 9
P Fortun (2000_CR6) 2008; 101
A Arora (2000_CR4) 2011; 32
O Berger (2000_CR9) 2009; 20
J Flory (2000_CR28) 2004; 292
K Matsui (2000_CR21) 2012; 22
ME Enama (2000_CR23) 2012; 33
K Sato (2000_CR24) 2014; 11
2000_CR14
P Knapp (2000_CR3) 2009; 35
V Sanchini (2000_CR29) 2014; 40
SM Sharp (2000_CR8) 2004; 27
E Beardsley (2000_CR13) 2007; 25
DW Fitzgerald (2000_CR7) 2002; 360
LB Dunn (2000_CR17) 2001; 24
DA Murphy (2000_CR20) 2007; 19
23728419 - J Med Ethics. 2014 Apr;40(4):269-75
17189020 - Lancet. 2006 Dec 23;368(9554):2205
12414207 - Lancet. 2002 Oct 26;360(9342):1301-2
23879694 - BMC Med Ethics. 2013;14:28
20233193 - Br J Clin Pharmacol. 2010 Mar;69(3):231-7
17265577 - AIDS Care. 2007 Jan;19(1):42-51
18922881 - Ann Oncol. 2009 Feb;20(2):379-85
25157899 - PLoS One. 2014;9(8):e105720
18487271 - QJM. 2008 Aug;101(8):625-9
19717698 - J Med Ethics. 2009 Sep;35(9):573-8
17391294 - Fundam Clin Pharmacol. 2007 Apr;21(2):207-14
22447213 - J Epidemiol. 2012;22(4):308-16
11331139 - Neuropsychopharmacology. 2001 Jun;24(6):595-607
16908486 - N Engl J Med. 2006 Sep 7;355(10):1018-28
21748435 - J Gen Intern Med. 2011 Nov;26(11):1324-8
21314779 - Acad Emerg Med. 2011 Feb;18(2):190-9
24408900 - Clin Trials. 2014 Feb;11(1):86-95
15467062 - JAMA. 2004 Oct 6;292(13):1593-601
21664491 - Contemp Clin Trials. 2011 Nov;32(6):814-7
21656146 - AIDS Behav. 2012 Feb;16(2):412-21
22542645 - Contemp Clin Trials. 2012 Sep;33(5):895-902
24734147 - J Clin Med Res. 2014 Jun;6(3):205-8
15577434 - Am J Clin Oncol. 2004 Dec;27(6):570-5
12594317 - N Engl J Med. 2003 Feb 20;348(8):721-6
17369564 - J Clin Oncol. 2007 Mar 20;25(9):e13-4
23656966 - Am J Ther. 2013 May-Jun;20(3):257-60
22698536 - JACC Cardiovasc Imaging. 2012 Jun;5(6):649-55
References_xml – volume: 24
  start-page: 595
  issue: 6
  year: 2001
  end-page: 607
  ident: CR17
  article-title: Enhancing informed consent for research and treatment
  publication-title: Neuropsychopharmacology
  doi: 10.1016/S0893-133X(00)00218-9
– volume: 16
  start-page: 412
  issue: 2
  year: 2012
  end-page: 421
  ident: CR19
  article-title: Improving participant understanding of informed consent in an HIV-prevention clinical trial: a comparison of methods
  publication-title: AIDS Behav
  doi: 10.1007/s10461-011-9977-z
– volume: 33
  start-page: 895
  issue: 5
  year: 2012
  end-page: 902
  ident: CR23
  article-title: Randomization to standard and concise informed consent forms: development of evidence-based consent practices
  publication-title: Contemp Clin Trials
  doi: 10.1016/j.cct.2012.04.005
– volume: 101
  start-page: 625
  issue: 8
  year: 2008
  end-page: 629
  ident: CR6
  article-title: Recall of informed consent information by healthy volunteers in clinical trials
  publication-title: QJM
  doi: 10.1093/qjmed/hcn067
– volume: 6
  start-page: 205
  issue: 3
  year: 2014
  end-page: 208
  ident: CR15
  article-title: Informed consent for phase I oncology trials: form, substance and signature
  publication-title: J Clin Med Res
– ident: CR14
– year: 2002
  ident: CR18
  publication-title: When generations collide
– volume: 355
  start-page: 1018
  issue: 10
  year: 2006
  end-page: 1028
  ident: CR1
  article-title: Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa063842
– volume: 360
  start-page: 1301
  issue: 9342
  year: 2002
  end-page: 1302
  ident: CR7
  article-title: Comprehension during informed consent in a less-developed country
  publication-title: Lancet
  doi: 10.1016/S0140-6736(02)11338-9
– volume: 40
  start-page: 269
  issue: 4
  year: 2014
  end-page: 275
  ident: CR29
  article-title: Informed consent as an ethical requirement in clinical trials: an old, but still unresolved issue. an observational study to evaluate patient’s informed consent comprehension
  publication-title: J Med Ethics
  doi: 10.1136/medethics-2012-101115
– volume: 348
  start-page: 721
  issue: 8
  year: 2003
  end-page: 726
  ident: CR11
  article-title: Readability standards for informed-consent forms as compared with actual readability
  publication-title: N Engl J Med
  doi: 10.1056/NEJMsa021212
– volume: 20
  start-page: 257
  issue: 3
  year: 2013
  end-page: 260
  ident: CR5
  article-title: Credibility and comprehension of healthy volunteers in lengthy inpatient drug studies
  publication-title: Am J Ther
  doi: 10.1097/MJT.0b013e3182811a9e
– volume: 21
  start-page: 207
  issue: 2
  year: 2007
  end-page: 214
  ident: CR25
  article-title: Improvement of the comprehension of written information given to healthy volunteers in biomedical research: a single-blind randomized controlled study
  publication-title: Fundam Clin Pharmacol
  doi: 10.1111/j.1472-8206.2007.00472.x
– volume: 5
  start-page: 649
  issue: 6
  year: 2012
  end-page: 655
  ident: CR12
  article-title: Low quality and lack of clarity of current informed consent forms in cardiology: how to improve them
  publication-title: JACC Cardiovasc Imaging
  doi: 10.1016/j.jcmg.2012.03.007
– volume: 35
  start-page: 573
  issue: 9
  year: 2009
  end-page: 578
  ident: CR3
  article-title: Performance-based readability testing of participant materials for a phase I trial: TGN1412
  publication-title: J Med Ethics
  doi: 10.1136/jme.2008.026708
– volume: 9
  start-page: e105720
  issue: 8
  year: 2014
  ident: CR26
  article-title: Comparison of closed-ended, open-ended, and perceived informed consent comprehension measures for a mock HIV prevention trial among women in Tanzania
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0105720
– volume: 26
  start-page: 1324
  issue: 11
  year: 2011
  end-page: 1328
  ident: CR10
  article-title: Length and complexity of US and international HIV consent forms from federal HIV network trials
  publication-title: J Gen Intern Med
  doi: 10.1007/s11606-011-1778-6
– volume: 18
  start-page: 190
  issue: 2
  year: 2011
  end-page: 199
  ident: CR27
  article-title: Generational influences in academic emergency medicine: teaching and learning, mentoring, and technology (part I)
  publication-title: Acad Emerg Med
  doi: 10.1111/j.1553-2712.2010.00985.x
– volume: 292
  start-page: 1593
  issue: 13
  year: 2004
  end-page: 1601
  ident: CR28
  article-title: Interventions to improve research participants’ understanding in informed consent for research: a systematic review
  publication-title: JAMA
  doi: 10.1001/jama.292.13.1593
– volume: 368
  start-page: 2205
  issue: 9554
  year: 2006
  ident: CR2
  article-title: Risk in drug trials
  publication-title: Lancet
  doi: 10.1016/S0140-6736(06)69881-4
– volume: 20
  start-page: 379
  issue: 2
  year: 2009
  end-page: 385
  ident: CR9
  article-title: The length of consent documents in oncological trials is doubled in twenty years
  publication-title: Ann Oncol
  doi: 10.1093/annonc/mdn623
– volume: 14
  start-page: 28
  year: 2013
  ident: CR16
  article-title: Improving understanding in the research informed consent process: a systematic review of 54 interventions tested in randomized control trials
  publication-title: BMC Med Ethics
  doi: 10.1186/1472-6939-14-28
– volume: 19
  start-page: 42
  issue: 1
  year: 2007
  end-page: 51
  ident: CR20
  article-title: Improving comprehension for HIV vaccine trial information among adolescents at risk of HIV
  publication-title: AIDS Care
  doi: 10.1080/09540120600680882
– volume: 69
  start-page: 231
  issue: 3
  year: 2010
  end-page: 237
  ident: CR22
  article-title: Informed consent document improvement does not increase patients’ comprehension in biomedical research
  publication-title: Br J Clin Pharmacol
  doi: 10.1111/j.1365-2125.2009.03565.x
– volume: 27
  start-page: 570
  issue: 6
  year: 2004
  end-page: 575
  ident: CR8
  article-title: Consent documents for oncology trials: does anybody read these things?
  publication-title: Am J Clin Oncol
  doi: 10.1097/01.coc.0000135925.83221.b3
– volume: 11
  start-page: 86
  issue: 1
  year: 2014
  end-page: 95
  ident: CR24
  article-title: Satisfying the needs of Japanese cancer patients: a comparative study of detailed and standard informed consent documents
  publication-title: Clin Trials
  doi: 10.1177/1740774513515550
– volume: 25
  start-page: e13
  issue: 9
  year: 2007
  end-page: e14
  ident: CR13
  article-title: Longer consent forms for clinical trials compromise patient understanding: so why are they lengthening?
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2006.10.3341
– volume: 22
  start-page: 308
  issue: 4
  year: 2012
  end-page: 316
  ident: CR21
  article-title: A randomized controlled trial of short and standard-length consent forms for a genetic cohort study: is longer better?
  publication-title: J Epidemiol
  doi: 10.2188/jea.JE20110104
– volume: 32
  start-page: 814
  issue: 6
  year: 2011
  end-page: 817
  ident: CR4
  article-title: Development of tool for the assessment of comprehension of informed consent form in healthy volunteers participating in first-in-human studies
  publication-title: Contemp Clin Trials
  doi: 10.1016/j.cct.2011.05.012
– volume: 26
  start-page: 1324
  issue: 11
  year: 2011
  ident: 2000_CR10
  publication-title: J Gen Intern Med
  doi: 10.1007/s11606-011-1778-6
– volume: 22
  start-page: 308
  issue: 4
  year: 2012
  ident: 2000_CR21
  publication-title: J Epidemiol
  doi: 10.2188/jea.JE20110104
– volume: 35
  start-page: 573
  issue: 9
  year: 2009
  ident: 2000_CR3
  publication-title: J Med Ethics
  doi: 10.1136/jme.2008.026708
– volume: 6
  start-page: 205
  issue: 3
  year: 2014
  ident: 2000_CR15
  publication-title: J Clin Med Res
– volume: 5
  start-page: 649
  issue: 6
  year: 2012
  ident: 2000_CR12
  publication-title: JACC Cardiovasc Imaging
  doi: 10.1016/j.jcmg.2012.03.007
– volume: 20
  start-page: 257
  issue: 3
  year: 2013
  ident: 2000_CR5
  publication-title: Am J Ther
  doi: 10.1097/MJT.0b013e3182811a9e
– volume: 24
  start-page: 595
  issue: 6
  year: 2001
  ident: 2000_CR17
  publication-title: Neuropsychopharmacology
  doi: 10.1016/S0893-133X(00)00218-9
– volume: 32
  start-page: 814
  issue: 6
  year: 2011
  ident: 2000_CR4
  publication-title: Contemp Clin Trials
  doi: 10.1016/j.cct.2011.05.012
– volume: 27
  start-page: 570
  issue: 6
  year: 2004
  ident: 2000_CR8
  publication-title: Am J Clin Oncol
  doi: 10.1097/01.coc.0000135925.83221.b3
– volume: 18
  start-page: 190
  issue: 2
  year: 2011
  ident: 2000_CR27
  publication-title: Acad Emerg Med
  doi: 10.1111/j.1553-2712.2010.00985.x
– volume: 19
  start-page: 42
  issue: 1
  year: 2007
  ident: 2000_CR20
  publication-title: AIDS Care
  doi: 10.1080/09540120600680882
– volume: 292
  start-page: 1593
  issue: 13
  year: 2004
  ident: 2000_CR28
  publication-title: JAMA
  doi: 10.1001/jama.292.13.1593
– ident: 2000_CR14
– volume: 101
  start-page: 625
  issue: 8
  year: 2008
  ident: 2000_CR6
  publication-title: QJM
  doi: 10.1093/qjmed/hcn067
– volume: 360
  start-page: 1301
  issue: 9342
  year: 2002
  ident: 2000_CR7
  publication-title: Lancet
  doi: 10.1016/S0140-6736(02)11338-9
– volume: 33
  start-page: 895
  issue: 5
  year: 2012
  ident: 2000_CR23
  publication-title: Contemp Clin Trials
  doi: 10.1016/j.cct.2012.04.005
– volume: 11
  start-page: 86
  issue: 1
  year: 2014
  ident: 2000_CR24
  publication-title: Clin Trials
  doi: 10.1177/1740774513515550
– volume: 355
  start-page: 1018
  issue: 10
  year: 2006
  ident: 2000_CR1
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa063842
– volume: 16
  start-page: 412
  issue: 2
  year: 2012
  ident: 2000_CR19
  publication-title: AIDS Behav
  doi: 10.1007/s10461-011-9977-z
– volume: 348
  start-page: 721
  issue: 8
  year: 2003
  ident: 2000_CR11
  publication-title: N Engl J Med
  doi: 10.1056/NEJMsa021212
– volume: 14
  start-page: 28
  year: 2013
  ident: 2000_CR16
  publication-title: BMC Med Ethics
  doi: 10.1186/1472-6939-14-28
– volume-title: When generations collide
  year: 2002
  ident: 2000_CR18
– volume: 69
  start-page: 231
  issue: 3
  year: 2010
  ident: 2000_CR22
  publication-title: Br J Clin Pharmacol
  doi: 10.1111/j.1365-2125.2009.03565.x
– volume: 20
  start-page: 379
  issue: 2
  year: 2009
  ident: 2000_CR9
  publication-title: Ann Oncol
  doi: 10.1093/annonc/mdn623
– volume: 9
  start-page: e105720
  issue: 8
  year: 2014
  ident: 2000_CR26
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0105720
– volume: 21
  start-page: 207
  issue: 2
  year: 2007
  ident: 2000_CR25
  publication-title: Fundam Clin Pharmacol
  doi: 10.1111/j.1472-8206.2007.00472.x
– volume: 25
  start-page: e13
  issue: 9
  year: 2007
  ident: 2000_CR13
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2006.10.3341
– volume: 368
  start-page: 2205
  issue: 9554
  year: 2006
  ident: 2000_CR2
  publication-title: Lancet
  doi: 10.1016/S0140-6736(06)69881-4
– volume: 40
  start-page: 269
  issue: 4
  year: 2014
  ident: 2000_CR29
  publication-title: J Med Ethics
  doi: 10.1136/medethics-2012-101115
– reference: 22447213 - J Epidemiol. 2012;22(4):308-16
– reference: 17391294 - Fundam Clin Pharmacol. 2007 Apr;21(2):207-14
– reference: 12594317 - N Engl J Med. 2003 Feb 20;348(8):721-6
– reference: 19717698 - J Med Ethics. 2009 Sep;35(9):573-8
– reference: 21656146 - AIDS Behav. 2012 Feb;16(2):412-21
– reference: 18922881 - Ann Oncol. 2009 Feb;20(2):379-85
– reference: 20233193 - Br J Clin Pharmacol. 2010 Mar;69(3):231-7
– reference: 15577434 - Am J Clin Oncol. 2004 Dec;27(6):570-5
– reference: 21748435 - J Gen Intern Med. 2011 Nov;26(11):1324-8
– reference: 21314779 - Acad Emerg Med. 2011 Feb;18(2):190-9
– reference: 15467062 - JAMA. 2004 Oct 6;292(13):1593-601
– reference: 18487271 - QJM. 2008 Aug;101(8):625-9
– reference: 16908486 - N Engl J Med. 2006 Sep 7;355(10):1018-28
– reference: 17369564 - J Clin Oncol. 2007 Mar 20;25(9):e13-4
– reference: 24408900 - Clin Trials. 2014 Feb;11(1):86-95
– reference: 17265577 - AIDS Care. 2007 Jan;19(1):42-51
– reference: 25157899 - PLoS One. 2014;9(8):e105720
– reference: 12414207 - Lancet. 2002 Oct 26;360(9342):1301-2
– reference: 24734147 - J Clin Med Res. 2014 Jun;6(3):205-8
– reference: 21664491 - Contemp Clin Trials. 2011 Nov;32(6):814-7
– reference: 23728419 - J Med Ethics. 2014 Apr;40(4):269-75
– reference: 23879694 - BMC Med Ethics. 2013;14:28
– reference: 22542645 - Contemp Clin Trials. 2012 Sep;33(5):895-902
– reference: 11331139 - Neuropsychopharmacology. 2001 Jun;24(6):595-607
– reference: 22698536 - JACC Cardiovasc Imaging. 2012 Jun;5(6):649-55
– reference: 23656966 - Am J Ther. 2013 May-Jun;20(3):257-60
– reference: 17189020 - Lancet. 2006 Dec 23;368(9554):2205
SSID ssj0015903
Score 2.2061791
Snippet Purpose This study aimed to evaluate the applicability of the principles and informed consent form (ICF) template proposed by the Strategic Initiative for...
This study aimed to evaluate the applicability of the principles and informed consent form (ICF) template proposed by the Strategic Initiative for Developing...
Purpose This study aimed to evaluate the applicability of the principles and informed consent form (ICF) template proposed by the Strategic Initiative for...
PURPOSEThis study aimed to evaluate the applicability of the principles and informed consent form (ICF) template proposed by the Strategic Initiative for...
SourceID pubmedcentral
proquest
pubmed
crossref
springer
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 413
SubjectTerms Adolescent
Adult
Aged
Biomedical and Life Sciences
Biomedical Research - ethics
Biomedicine
Clinical Trial
Clinical trials
Comprehension
Consent Forms
Female
Healthy Volunteers
Humans
Informed Consent
Knowledge
Male
Middle Aged
Pharmacology/Toxicology
Research Design
Surveys and Questionnaires
Volunteers
Young Adult
SummonAdditionalLinks – databaseName: ProQuest Central Database Suite (ProQuest)
  dbid: BENPR
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagvXBBvAkUZCRUJKiF4yR2zAVB2apwqFallXqL_CwrlezSzR6WP8DfZux4s10qeow8dmLNeGbimfkGoddeidxzJYivakVKICLSmpwIVvlQMiK0jgmyR_zwtPx2Vp2lC7d5Sqtc6cSoqO3UhDvy97kQBZgXwfjH2S8SukaF6GpqoXEbbYMKrkHOtz-PjsbHQxyhkjTB7uaESzHENWmEEWUBnTmvSCyvZpuW6Zq7eT1r8p_QabRIB_fQ3eRK4k897--jW659gHbHPRb1cg-frEur5nt4F4_XKNXLh-hPf53gLJ6plFrddvM3eHG12gVPWqxwXyu5xEGTAR_cJY6gtDjkzJ9j8CDx969f9kfHuEdhhSVNyNFuOxweP8AKYBDt9Ofkt7Mk5cZfAFVc5RE6PRid7B-S1JWBmFLQjnhwqZyX0nhTelMwKinVpXaaG_CNuJSlMtaKXHNqHNWF9lznQrsCiDzToniMttpp654iXJXW2VooSZkvTQFiwaWt4Z_NGu1rpTJEVxxpTIIsD50zLpoBbDkysQEmhn6atGEZejtMmfV4HTcR76zY3KSjO2_WgpahV8MwHLoQSVGtmy4iDTg-QtZ5hp70UjG8jfHw31_AbLEhLwNBAPTeHGknPyKwdxnAHIsqQ-9WknXls_63iWc3b-I5ugM-Hu-TjXbQVne5cC_Aj-r0y3RY_gJk6x7u
  priority: 102
  providerName: ProQuest
Title Improved participants’ understanding in a healthy volunteer study using the SIDCER informed consent form: a randomized-controlled study
URI https://link.springer.com/article/10.1007/s00228-015-2000-2
https://www.ncbi.nlm.nih.gov/pubmed/26713336
https://www.proquest.com/docview/1773238726
https://www.proquest.com/docview/1774157981
https://pubmed.ncbi.nlm.nih.gov/PMC4792335
Volume 72
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1bb9MwFLage-GF-yUwKiOhPcA8OTc75q0tLQOkqhqtVJ4i27GhYqTTmj50T7zyE_h7_BKOc9u6AdJeEkU-cWL52P6S853PCL20kvuWSU5snEgSgRERmfYJD2LrUka4UiVBdswOZ9GHeTyv87hXDdu9CUmWM3Wb7FZKtcCnb0zKdGiYd3diPxFJB-303n3-OGyDB7GgtdauT5jgbTDzb5VsL0dXMOZVquSleGm5DI3uoGnTgIp98u1gXagDfXZJ2_GaLbyLbtewFPcqP7qHbpj8PtqbVLrWm308PU_TWu3jPTw5V7zePEA_q18TJsMnsqZp58Xq949feH0xdwYvcixxlXm5wW5ehF41p7iUuMWOgf8FAx7Fn96_HQyPcKXpCpVqx_jOC-wu30ANsLxmy--LM5ORmml_DFZlLQ_RbDScDg5JvccD0RGnBbEA0IwVQlsdWR0GVFCqImUU04C0mBCR1FnGfcWoNlSFyjLlc2VCMLKB4uEj1MmXuXmCcBxlJku4FDSwkQ7ByZjIEvgCzLSyiZQeok1Xp7oWQHf7cBynrXRz2QEpdIDbnZOmgYdetbecVOof_zPebfwnrSeCVepzHgIq4gHz0Iu2GIawi8vI3CzXpQ3AKC4S30OPK3drnxYw9xchhLv5liO2Bk4efLskX3wtZcIjJw0Zxh563Xjbhdf6VyOeXsv6GboFAJJVTKZd1ClO1-Y5gLRCddFNPuddGJqjfn_crYconPvD8eQISgdsAMdZ0PsD3do-NQ
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELdG9wAviG86BhgJhgSzcJzEjpEQgq1Ty0ZVjU7aW4i_RqWRlrUVKv8A_w1_I-d8dWVib3uMfL7EurPv4rv7HULPXSYCxzNBXJxkJAIiIo0OiGCx8yUjQqkiQbbPu0fRp-P4eA39qWthfFplfSYWB7UZa39H_iYQIgTzIhh_P_lBfNcoH12tW2iUarFvFz_hl236rrcL8n3B2F5nuNMlVVcBoiNBZ8SBS2CdlNrpyOmQUUmpipRVXINt51JGmTZGBIpTbakKleMqEMqGQOSYEiHwvYbWI1_R2kLrHzv9wWETt4glrWB-A8KlaOKotIAtZR4NOohJUc7NVi3hBff2YpbmP6HawgLu3UI3K9cVfyh17TZas_kdtDUosa8X23i4LOWabuMtPFiiYi_uot_l9YU1eJJVqdz5bPoSz89X1-BRjjNc1mYusD85Qe72DBcguNjn6J9g8Fjxl97uTucQl6ivwFL7nPB8hv3jW-AABtiMv49-WUOqXPxToCq43ENHVyKv-6iVj3P7EOE4MtYkIpOUuUiHoIZcmgT-EY1WLsmyNqK1RFJdQaT7Th2naQPuXAgxBSH6_p00ZW30qpkyKfFBLiPerMWcVkfFNF0qdhs9a4Zhk_vITZbb8bygAUdLyCRoowelVjRvY9zfM4QwW6zoS0PgAcRXR_LRtwJIPPLgkWHcRq9rzTr3Wf9bxMbli3iKrneHnw_Sg15__xG6Af4lLxOdNlFrdja3j8GHm6kn1cbB6OtV79W_1qtd1w
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1tb9MwELZGJyG-IN7JGGAkGBLMmuMkdo2EEKytVoaqamzSvmXxG1Ta0rK2QuUP8J_4dZzz1pWJfdvHKBcn1p19F99zzyH00mUidDwTxCXtjMQgRKTRIREscb5kRChVAGQHfO8o_nycHK-hP3UtjIdV1ntisVGbsfZn5DuhEBG4F8H4jqtgEcNO78PkB_EdpHymtW6nUZrIvl38hN-36ft-B3T9irFe93B3j1QdBoiOBZ0RB-GBdVJqp2OnI0YlpSpWVnENfp5LGWfaGBEqTrWlKlKOq1AoG4GQY0pEMO4NtC7AK8YttP6pOxgeNDmMRNKK8jckXIomp0oLClPmmaHDhBSl3WzVK14KdS8jNv9J2xbesHcH3a7CWPyxtLu7aM3m99DWsOTBXmzjw2VZ13Qbb-HhkiF7cR_9Lo8yrMGTrIJ157Ppazy_WGmDRznOcFmnucB-FwUbsOe4IMTFHq__DUP0ir_2O7vdA1wywMKQ2uPD8xn2l-9gBHDGZnw2-mUNqXD5pyBVjPIAHV2Lvh6iVj7O7WOEk9hY0xaZpMzFOgKT5NK04X_RaOXaWRYgWmsk1RVduu_acZo2RM-FElNQou_lSVMWoDfNI5OSK-Qq4c1azWm1bUzTpZEH6EVzGxa8z-JkuR3PCxkIuoRshwF6VFpF8zbG_ZlDBE-LFXtpBDyZ-OqdfPS9IBWPPZFklATobW1ZFz7rf5PYuHoSz9FNWKPpl_5g_wm6BaEmLzFPm6g1O5_bpxDOzdSzat1gdHLdS_Uv0cJiAw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Improved+participants%27+understanding+in+a+healthy+volunteer+study+using+the+SIDCER+informed+consent+form%3A+a+randomized-controlled+study&rft.jtitle=European+journal+of+clinical+pharmacology&rft.au=Koonrungsesomboon%2C+Nut&rft.au=Teekachunhatean%2C+Supanimit&rft.au=Hanprasertpong%2C+Nutthiya&rft.au=Laothavorn%2C+Junjira&rft.date=2016-04-01&rft.eissn=1432-1041&rft.volume=72&rft.issue=4&rft.spage=413&rft.epage=421&rft_id=info:doi/10.1007%2Fs00228-015-2000-2&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0031-6970&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0031-6970&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0031-6970&client=summon